‘Covering the tail’ after stopping efavirenz-based antiretroviral therapy

por Maartens, Gary
Publicado 2020

Linezolid for Treating Tuberculosis: A Delicate Balancing Act

por Maartens, Gary, Benson, Constance A.
Publicado 2015

Performance of Serum C-Reactive Protein as a Screening Test for Smear-Negative Tuberculosis in an Ambulatory High HIV Prevalence Population

por Wilson, Douglas, Badri, Motasim, Maartens, Gary
Publicado 2011

Dolutegravir for second-line treatment: Programmatic implications of new evidence

por Zhao, Ying, Maartens, Gary, Meintjes, Graeme
Publicado 2022

Systematic Review of Antiretroviral-Associated Lipodystrophy: Lipoatrophy, but Not Central Fat Gain, Is an Antiretroviral Adverse Drug Reaction

por de Waal, Reneé, Cohen, Karen, Maartens, Gary
Publicado 2013

Weight gain on dolutegravir: Association is not the same as causation

por Maartens, Gary, Sinxadi, Phumla, Venter, W.D. Francois
Publicado 2023

Abdominal Ultrasound for the Diagnosis of Tuberculosis Among Human Immunodeficiency Virus-Positive Inpatients With World Health Organization Danger Signs

por Griesel, Rulan, Cohen, Karen, Mendelson, Marc, Maartens, Gary
Publicado 2019

Standard versus double dose dolutegravir in patients with HIV-associated tuberculosis: a phase 2 non-comparative randomised controlled (RADIANT-TB) trial

por Griesel, Rulan, Hill, Andrew, Meintjes, Graeme, Maartens, Gary
Publicado 2021

Factors Influencing Retention in Care after Starting Antiretroviral Therapy in a Rural South African Programme

por Boyles, Tom H., Wilkinson, Lynne S., Leisegang, Rory, Maartens, Gary
Publicado 2011

Changes in blood pressure, glucose levels, insulin secretion and anthropometry after long term exposure to antiretroviral therapy in South African women

por Abrahams, Zulfa, Dave, Joel A, Maartens, Gary, Levitt, Naomi S
Publicado 2015

Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps

por Murphy, Richard A., Court, Richard, Maartens, Gary, Sunpath, Henry
Publicado 2017

Patient and provider delay in tuberculosis suspects from communities with a high HIV prevalence in South Africa: A cross-sectional study

por Meintjes, Graeme, Schoeman, Hennie, Morroni, Chelsea, Wilson, Douglas, Maartens, Gary
Publicado 2008

Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings

por Leisegang, Rory, Maartens, Gary, Hislop, Michael, Regensberg, Leon, Cleary, Susan
Publicado 2010

Global HIV/AIDS Clinical and Translational Pharmacology

por Morse, Gene D., Maartens, Gary, Maponga, Charles Chiedza, Ma, Qing
Publicado 2012

Renal safety of lithium in HIV-infected patients established on tenofovir disoproxil fumarate containing antiretroviral therapy: analysis from a randomized placebo-controlled trial

por Decloedt, Eric H., Lesosky, Maia, Maartens, Gary, Joska, John A.
Publicado 2017

Correlation of hair and plasma efavirenz concentrations in HIV-positive South Africans

por Johnston, Jenna, Wiesner, Lubbe, Smith, Peter, Maartens, Gary, Orrell, Catherine
Publicado 2019

Clofazimine for the treatment of tuberculosis

por Stadler, Jacob A. M., Maartens, Gary, Meintjes, Graeme, Wasserman, Sean
Publicado 2023

The development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settings

por Abrahams, Zulfa, Dave, Joel A, Maartens, Gary, Lesosky, Maia, Levitt, Naomi S
Publicado 2014

Factors associated with loss to follow-up after occupational HIV exposure in Cape Town, South Africa: a retrospective cohort study

por Papavarnavas, Nectarios Sophocles, Manning, Kathryn, Conrad, Fahd, Govender, Milah, Maartens, Gary
Publicado 2017

Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV

por Boyles, Tom H., Griesel, Rulan, Stewart, Annemie, Mendelson, Marc, Maartens, Gary
Publicado 2018